HYUNDAI PHARMACEUTICAL CO., LTD.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 1965-01-01
- Employees
- 501
- Market Cap
- -
Clinical Trials
11
Active:0
Completed:9
Trial Phases
3 Phases
Phase 1:8
Phase 2:1
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Phase 1
8 (72.7%)Phase 3
2 (18.2%)Phase 2
1 (9.1%)HDDO-1756 Bio Equivalence Study
- First Posted Date
- 2021-02-16
- Last Posted Date
- 2021-02-17
- Lead Sponsor
- Hyundai Pharmaceutical Co., LTD.
- Target Recruit Count
- 56
- Registration Number
- NCT04755894
- Locations
- 🇰🇷
Hyundai Pharm, Seoul, Korea, Republic of
BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2020-04-22
- Lead Sponsor
- Hyundai Pharmaceutical Co., LTD.
- Target Recruit Count
- 712
- Registration Number
- NCT04229927
- Locations
- 🇰🇷
Inha University Hospital, Incheon, Korea, Republic of
HDDO-1801 Intervention Trial
Phase 1
- Conditions
- Respiratory Disease
- Interventions
- Drug: Combinations
- First Posted Date
- 2019-09-20
- Last Posted Date
- 2019-09-20
- Lead Sponsor
- Hyundai Pharmaceutical Co., LTD.
- Target Recruit Count
- 36
- Registration Number
- NCT04097951
- Locations
- 🇰🇷
Inha University Hospital, Junggu, Incheon, Korea, Republic of
HDDO-1614 Bio Equivalence Study
Phase 1
Completed
- Conditions
- Osteoporosis
- Interventions
- Combination Product: HDDO-1614
- First Posted Date
- 2017-12-22
- Last Posted Date
- 2018-02-26
- Lead Sponsor
- Hyundai Pharmaceutical Co., LTD.
- Target Recruit Count
- 38
- Registration Number
- NCT03382314
- Locations
- 🇰🇷
Inha University Hospital, Junggu, Incheon, Korea, Republic of
HDDO-1614 Intervention Trial
Phase 1
Completed
- Conditions
- Osteoporosis
- Interventions
- First Posted Date
- 2017-07-31
- Last Posted Date
- 2017-12-11
- Lead Sponsor
- Hyundai Pharmaceutical Co., LTD.
- Target Recruit Count
- 37
- Registration Number
- NCT03234244
- Locations
- 🇰🇷
Inha University Hospital, Junggu, Incheon, Korea, Republic of
- Prev
- 1
- 2
- 3
- Next
News
No news found